Related Experiment Videos
RET gene and its implications for cancer
1Department of Surgery, Washington University School of Medicine, St. Louis, MO 63110, USA.
Journal of the National Cancer Institute
|October 18, 1995
Summary
The RET proto-oncogene is linked to inherited and sporadic thyroid cancers. Detecting RET mutations aids in identifying carriers and understanding cancer development.
Area of Science:
- Oncology
- Genetics
- Molecular Biology
Background:
- The RET proto-oncogene encodes a receptor tyrosine kinase.
- RET mutations are implicated in inherited cancer syndromes like Multiple Endocrine Neoplasia (MEN) types 2A and 2B, and Familial Medullary Thyroid Carcinoma (FMTC).
- These mutations are also found in sporadic thyroid carcinomas.
Purpose of the Study:
- To investigate the role of RET mutations in tumorigenesis.
- To explore the diagnostic potential of direct RET mutation detection.
- To understand the functional impact of RET mutations on protein activity.
Main Methods:
- Direct detection of RET mutations.
- In vivo and in vitro functional studies of RET mutations.
- Analysis of RET's role in cancer development.
Main Results:
- Direct detection of RET mutations can identify carriers of disease alleles before clinical manifestation.
- RET mutations are associated with both inherited and sporadic thyroid cancers.
- Studies have elucidated the effects of RET mutations on protein function.
Conclusions:
- RET mutation analysis is valuable for genetic screening in hereditary cancer syndromes.
- Understanding RET's function provides insights into general mechanisms of tumorigenesis.
- RET plays a critical role in the development of various thyroid malignancies.